European Seminars in Virology (EuSeV)


The “European Seminars in Virology” (EuSeV) are meant to be small, single-theme, highly attractive meetings for young European virologists, particularly PhD students and post-docs, in addition to senior virologists willing to participate. The talks are delivered by a selected group of Speakers. The topic of the EuSeV varies each time, and covers different aspects of basic, medical or clinical virology. The long term objective is to provide an instrument for doctoral and post-doctoral education and training, and to make a focus on key issues, thus implementing Virology in Europe.

Upcoming Event

11th European Seminar in Virology (EuSeV)

“Viral Vectors – from Basic Research to Clinical Application”

October 21–23, 2024
Bertinoro, Italy

In recent years, the development of powerful viral gene transfer systems has greatly facilitated both basic research and the development of novel prophylactic and therapeutic approaches. For instance, rabies viral vectors have become important components of neuroscience research and a variety of viruses such as adenoviruses, poxviruses, herpesviruses or vesicular stomatitis virus have been engineered into efficient vaccine vectors. Moreover, within the past 5 years the gene therapy field has seen a wave of drugs based on viral vectors that have gained regulatory approval. These modalities range from vector-based cancer therapies and immunotherapies including CAR-T cell therapy to treating genetic diseases including genome editing. The focus of this EuSeV will be to promote the exchange of concepts and ideas on which viral vectors are most suitable for specific purposes and how viral vectors and their delivery could be further improved for their use in basic research and clinical application. The exciting program, with eminent state-of-the art speakers, will cover a broad range of viruses that are used as vector systems including adenoviruses, adeno associated viruses, arenaviruses, herpesviruses and retroviruses. Topics will include strategies for optimization of vectors such as changing cell tropism or the use of specific regulatory elements. Furthermore, challenges concerning the development and translation of vectors to clinical settings will be addressed.

Confirmed keynote speakers: John Bell (Canada), Gabriella Campadelli-Fiume (Italy), Luka Cicin-Sain (Germany), Klaus Früh (USA), Dirk Grimm (Germany), Seppo Ylä-Herrttuala (Finland), Anita Milicic (UK), Danel Pinschewer (Switzerland), Cristian Smerdou (Spain), César Trigueros (Spain), Guy Ungerechts (Germany)

More information

Link to registration

Past EuSeVs